{"url_path":"/sec/avxl/8-k/2026-08-11/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1314052/0001731122-26-001042-index.html","accession_number":"0001731122-26-001042","cik":"0001314052","ticker":"AVXL","issuer_name":"ANAVEX LIFE SCIENCES CORP.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1314052/0001731122-26-001042-index.html","primary_entity_key":"0001314052","primary_entity_name":"ANAVEX LIFE SCIENCES CORP."},"word_count":303,"has_tables":true,"body_markdown":"false\n0001314052\n\n0001314052\n\n2026-08-11\n2026-08-11\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n \n\n** **\n\n**UNITED\nSTATES\nSECURITIES AND EXCHANGE COMMISSION****WASHINGTON, D.C. 20549**\n\n** **\n\n**FORM\n8-K**\n\n** **\n\n**CURRENT REPORT**\n\n** **\n\n**Pursuant to Section 13 or 15(d) of the Securities\nExchange Act of 1934**\n\n**Date of Report (Date of earliest event reported): August 11, 2026**\n\n** **\n\n**ANAVEX\nLIFE SCIENCES CORP.**\n\n**(Exact name of Registrant as Specified in Its Charter)**\n\n** **\n\n**Nevada**\n**001-37606**\n**98-0608404**\n\n**(State or Other Jurisdiction\nof Incorporation)**\n**(Commission File Number)**\n**(IRS Employer\nIdentification No.)**\n\n \n \n \n \n \n\n**630 5th Avenue, 20th Floor**\n\n**New York, NY USA**\n\n \n**10111**\n\n**(Address of Principal Executive Offices)**\n \n**(Zip Code)**\n\n \n\n**Registrant’s Telephone Number, Including Area Code: 1-844-689-3939**\n\n \n\nCheck the appropriate box below if the Form 8-K filing is intended to simultaneously\nsatisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n☐ Written communications\npursuant to Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n\n☐ Soliciting material pursuant\nto Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)\n\n \n\n☐ Pre-commencement\ncommunications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n☐ Pre-commencement\ncommunications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\n**Securities registered pursuant to Section 12(b) of the Act:**\n\n** **\n\n**Title of each class**\n \n**Trading Symbol(s)**\n \n**Name of each exchange on which registered**\n\nCommon Stock, par value $0.001 per share\n \nAVXL\n \nNasdaq Stock Market LLC\n\n \n\nIndicate by check mark whether the registrant is an emerging growth company\nas defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act\nof 1934 (§ 240.12b-2 of this chapter).\n\n \n\nEmerging growth company ☐\n\n \n\nIf an emerging growth company, indicate by check mark if the registrant\nhas elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant\nto Section 13(a) of the Exchange Act. ☐"}